Literature DB >> 15876998

Circulating markers of inflammation are related to carotid artery atherosclerosis.

P T Larsson1, S Hallerstam, S Rosfors, N H Wallén.   

Abstract

AIM: The role of inflammation in atherothrombotic disorders is becoming increasingly recognized. The present study prospectively investigates relationships between inflammatory markers and hemostatic variables, and non-invasive measures of carotid artery atherosclerosis.
METHODS: Markers of hemostasis (sP-selectin and fibrinogen), cytokines (IL-6, IL-8, TNF-a and MCP-1), inflammatory variables (hsCRP, SAA and calprotectin) and cell adhesion molecules (ICAM-1 and VCAM-1) as well as ultrasonography of the carotid arteries were assessed in 111 consecutive outpatients with manifest or suspected coronary artery disease (CAD).
RESULTS: Thirty-eight patients with manifest cardiovascular disease had higher IL-6 (P < 0.01) but not hsCRP levels. Higher levels of IL-6, calprotectin and VCAM-1 (all P < 0.05) were found in 35 patients with carotid plaques. In the whole study population (n = 109) an increased common carotid artery lumen diameter (LD) and cross sectional intima-media area (CIMA) was related to higher IL-6, IL-8 and MCP-1 levels (all P < 0.05), and increased LD also to higher hsCRP, calprotectin (both P < 0.05), sP-selectin and fibrinogen levels (both P < 0.01). Both LD and CIMA were related to VCAM-1 (both P < 0.01), but not to ICAM-1 levels. The intima-media thickness of the carotid artery was only positively related to MCP-1 levels (P < 0.05). Only the relation between IL-6 and LD remained significant after adjustment for age, gender, body mass index, smoking status or present lipid-lowering treatment.
CONCLUSIONS: Several biomarkers of inflammation are related to ultrasonographic measures of carotid artery atherosclerosis in patients with moderate to high prevalence of CAD. IL-6 seems to be an independent and useful biomarker of atherosclerosis in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876998

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  23 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

Review 2.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

3.  Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.

Authors:  Kristin Angel; Sella A Provan; Magne K Fagerhol; Petter Mowinckel; Tore K Kvien; Dan Atar
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

Review 4.  Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Drug Des Devel Ther       Date:  2010-10-01       Impact factor: 4.162

5.  Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.

Authors:  Linda L Hushaw; Ray Sawaqed; Ghaleb Sweis; Jori Reigle; Anjali Gopal; Daniel Brandt; Nadia Sweis; James Curran; Timothy B Niewold; Nadera J Sweiss
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

6.  Brachial artery intima-media thickness and echogenicity in relation to lipids and markers of oxidative stress in elderly subjects:--the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) Study.

Authors:  Lars Lind; Jessika Andersson; Monika Rönn; Thomas Gustavsson; Peter Holdfelt; Johannes Hulthe; Anders Elmgren; Kersti Zilmer; Mihkel Zilmer
Journal:  Lipids       Date:  2007-11-15       Impact factor: 1.880

7.  An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion.

Authors:  Peter J Gianaros; Anna L Marsland; Dora C-H Kuan; Brittney L Schirda; J Richard Jennings; Lei K Sheu; Ahmad R Hariri; James J Gross; Stephen B Manuck
Journal:  Biol Psychiatry       Date:  2013-10-23       Impact factor: 13.382

8.  The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people.

Authors:  Robertina Giacconi; Elisa Muti; Marco Malavolta; Catia Cipriano; Laura Costarelli; Gianni Bernardini; Nazzarena Gasparini; Erminia Mariani; Vittorio Saba; Gianfranco Boccoli; Eugenio Mocchegiani
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

Review 9.  Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.

Authors:  Maureen McMahon; Bevra H Hahn
Journal:  Curr Opin Immunol       Date:  2007-12       Impact factor: 7.486

10.  Vascular Structure and Inflammation in a South African Population: The SABPA Study.

Authors:  Carla Swart; Leandi Lammertyn; Paul I Welsh; Shani Botha-Le Roux
Journal:  Pulse (Basel)       Date:  2019-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.